Post-hoc analyses of the EFFISAYIL 2 trial revealed improvements in Psoriasis Symptom Scale (PSS), Pain Visual Analog Scale ...
The findings highlight the potential benefits of newer biologics targeting IL-12, IL-23, and IL-17 while also raising ...
Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While ...
In a retrospective cohort study, ustekinumab and guselkumab show trends toward lower risk for herpes zoster in patients with ...
Mar. 3, 2025 — Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on ...
Apremilast improves disease severity and patient-reported outcomes among adults with psoriasis, regardless of genital involvement.
6d
News-Medical.Net on MSNNatural product derivative demonstrates promising therapeutic potential for psoriasisAnnouncing a new publication for Acta Materia Medica journal. Phosphodiesterase-4 (PDE4), a member of the phosphodiesterase ...
You may be able to manage mild psoriasis on your feet with home remedies such as moisturizers and over-the-counter treatments like hydrocortisone 1% cream. However, more severe psoriasis may ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results